Measuring commercial cannabis availability: findings from a multi-state surveillance study in the US
Abstract Introduction: Cannabis legalization enables greater access to commercial cannabis among adults. Little is known about the extent to which demand for cannabis is met by licit or illicit markets among states with medical-only or recreational cannabis laws, or no legalization. Methods: Annual sales values of medical and recreational tetrahydrocannabinol (THC), illicit THC, hemp-derived cannabidiol (CBD) and hemp-derived THC were estimated for 2024 in 12 US states by combining and triangulating data from national- and state-level public sources, Euromonitor’s Passport
This article is available to registered members
Create a free account to access our full library of peer-reviewed research on medical cannabis.
Join ā it's freeAlready a member? Log in
